Tempus AI Inc. (NASDAQ:TEM) announced the introduction of xM for treatment response monitoring/TRM. This new liquid biopsy ...

Shares of Tempus AI, Inc. (TEM) jumped 17% on Monday morning after the company announced a new liquid biopsy assay intended ...

Tempus AI Inc (NASDAQ:TEM) shares are moving higher Monday after the company introduced a new program to monitor ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the expansion of Tempus One?its generative AI clinical assistant?with ...

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence for healthcare, has announced the launch of Fuses, a ...

Valued at a market cap of $9.2 billion, Tempus AI stock went public in June 2024. Since its initial public offering, TEM stock has returned over 35% to shareholders. However, the ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

As scientists question the rise in early colon cancer cases, a new study is offering some potential answers. Colored scanning electron micrograph (SEM) of a macrophage white blood cell (center ...

Addressing Barriers in Palliative Care for Rural and Underserved Communities Changes to sexual function after cancer treatment are extremely prevalent, affecting up to 90% of female patients with ...

Tempus AI stock is trading at a nosebleed valuation, and despite the compelling long-term upside, it's not worth investing at ...

Artificial intelligence allows us to examine that data to identify certain types of heart disease sooner and get personalized treatment to the patient faster.